<DOC>
	<DOCNO>NCT00552604</DOCNO>
	<brief_summary>Study Objectives : To determine efficacy safety standardise extract Cannabis sativa give orally 2 time daily compare placebo relief muscle stiffness pain multiple sclerosis period 12 week . Study Patients : 400 patient multiple sclerosis ( age 18-64 , stable disease previous 6 month , ambulatory , antispasticity medication physiotherapy stabilise ≥ 30 day ) experience muscle stiffness ≥ 4 11-point numerical Likert scale baseline . Study treatment : Group 1 : Cannabis extract ( delta-9-THC 2.5mg , CBD 1.25 mg per capsule ) , flexible dose 5 mg 25 mg THC/d , administer twice daily , additionally previous antispasticity analgesic medication . Group 2 : Matched placebo , twice daily , additionally previous antispasticity analgesic medication . Treatment Schedule : Start dose 5 mg THC/d , individual dose titration increase 5 mg THC every 3 day , maximal total daily dose 25 mg THC , administer 2 equal dos base tolerability . Treatment duration : 12 week . Study sit : 20 neurological clinic United Kingdom .</brief_summary>
	<brief_title>MUltiple Sclerosis Extract Cannabis ( MUSEC ) Study</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Muscle Spasticity</mesh_term>
	<criteria>Signed informed consent . Diagnosis MS accord McDonald criterion . Current muscle stiffness ≥ 4 11point categorical rating scale . Ongoing troublesome muscle stiffness least 3 month . Stable disease previous 6 month . Antispasticity medication physiotherapy stabilise last 30 day . Patients may ambulatory . Age 1864 . Immunosuppressants may affect spasticity ( include corticosteroid interferon exclude azathioprine ) take currently previous 30 day Past present history psychotic illness . Open/infected pressure sores source chronic infection . Significant fix tendon contracture . Severe cognitive impairment patient unable provide inform consent . History clinically important renal , cardiovascular neurol . disease ( apart MS ) . Malignancy within past 2 year . Cannabinoids take currently previous 30 day . Positive qualitative urinary test cannabinoids screen visit . ( In case patient allow repeat test second screen visit later . ) Known hypersensitivity cannabinoids . Current drug abuse , include alcohol abuse . Laboratory parameter outside follow limit : Creatinine &gt; 3x upper limit normal Bilirubine &gt; 3x upper limit normal Transaminases &gt; 5 x upper limit normal Anticipated immunisation within 12 week trial participation . Other problem likely make participation difficult discretion neurologist . Women pregnant , lactate use adequate contraception . Participation treatment study currently within previous month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>multiple sclerosis</keyword>
	<keyword>muscle stiffness</keyword>
	<keyword>spasticity</keyword>
	<keyword>pain</keyword>
	<keyword>treatment</keyword>
	<keyword>cannabinoids</keyword>
</DOC>